Andrew S. Davis - 01 Feb 2023 Form 4 Insider Report for Silk Road Medical Inc

Role: Chief Commercial Officer
Signature: /s/Mhairi Jones, by power of attorney
Issuer symbol: N/A
Transactions as of: 01 Feb 2023
Net transactions value: -$333,058
Form type: 4
Filing time: 03 Feb 2023, 18:19:38 UTC
Previous filing: 04 Jan 2023
Next filing: 02 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILK	Common Stock	Options Exercise	$31,942	+6,753	+6.9%	$4.73	104,958	01 Feb 2023	Direct	F1
transaction	SILK	Common Stock	Sale	$365,000	-6,753	-6.4%	$54.05	98,205	01 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SILK	Option (right to buy)	Options Exercise	$0	-6,753	-11%	$0.000000	54,865	01 Feb 2023	Common Stock	6,753	$4.73	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on May 20, 2022.
F2	All of the shares subject to this option are fully vested and exercisable as of the date hereof.